X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
r-chop-14 (8) 8
humans (7) 7
antineoplastic combined chemotherapy protocols - adverse effects (6) 6
drug administration schedule (6) 6
female (6) 6
index medicus (6) 6
oncology (6) 6
treatment outcome (6) 6
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
chemotherapy (5) 5
cyclophosphamide - administration & dosage (5) 5
lymphoma, large b-cell, diffuse - drug therapy (5) 5
male (5) 5
middle aged (5) 5
aged (4) 4
antineoplastic combined chemotherapy protocols - administration & dosage (4) 4
cyclophosphamide (4) 4
cyclophosphamide - adverse effects (4) 4
dose-response relationship, drug (4) 4
doxorubicin - administration & dosage (4) 4
doxorubicin - adverse effects (4) 4
elderly-patients (4) 4
prednisone - administration & dosage (4) 4
prednisone - adverse effects (4) 4
rituximab (4) 4
vincristine - administration & dosage (4) 4
vincristine - adverse effects (4) 4
adult (3) 3
anthracyclines (3) 3
b-cell lymphoma (3) 3
cancer (3) 3
corticosteroids (3) 3
hematology, oncology and palliative medicine (3) 3
lymphomas (3) 3
non-hodgkins-lymphoma (3) 3
young-patients (3) 3
age factors (2) 2
aged patients (2) 2
aggressive lymphomas (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
antibodies, monoclonal, murine-derived - adverse effects (2) 2
care and treatment (2) 2
cyclophosphamide - therapeutic use (2) 2
diffuse large b-cell lymphoma (2) 2
disease-free survival (2) 2
dose intensity (2) 2
doxorubicin - therapeutic use (2) 2
febrile neutropenia (2) 2
filgrastim (2) 2
hematology (2) 2
lymphoma, large b-cell, diffuse - diagnosis (2) 2
neoplasm staging (2) 2
non-hodgkin-lymphoma (2) 2
prednisone (2) 2
prednisone - therapeutic use (2) 2
r-chop (2) 2
r-chop-21 (2) 2
standards (2) 2
survival analysis (2) 2
vincristine - therapeutic use (2) 2
3-weekly chop (1) 1
acvbp (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - surgery (1) 1
aged, 80 and over (1) 1
aggressive b-cell lymphoma (1) 1
aggressive lymphoma (1) 1
aluminum compounds (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal - adverse effects (1) 1
antibodies, monoclonal, murine-derived (1) 1
antibodies, monoclonal, murine-derived - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
article (1) 1
b cells (1) 1
biomedical research - methods (1) 1
biomedical research - trends (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - pathology (1) 1
breast neoplasms - surgery (1) 1
chemotherapy plus rituximab (1) 1
chemotherapy, adjuvant (1) 1
chi-square distribution (1) 1
china (1) 1
chop (1) 1
chop chemotherapy (1) 1
chop-14 (1) 1
cmf (1) 1
colony-stimulating factor (1) 1
colony-stimulating factors (1) 1
combined modality therapy (1) 1
comorbidity (1) 1
comparative analysis (1) 1
cost-effectiveness (1) 1
cycles (1) 1
daily filgrastim (1) 1
dense rituximab (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 6, pp. 525 - 533
Journal Article
British Journal of Haematology, ISSN 0007-1048, 06/2015, Volume 169, Issue 6, pp. 787 - 794
Summary The primary objective of this prospective, randomized study was to compare the efficacy of a reduced regimen of only four doses of unpegylated... 
R‐CHOP‐14 | G‐CSF | pegylated G‐CSF | diffuse large B‐cell lymphoma | R-CHOP-14 | G-CSF | Pegylated G-CSF | Diffuse large B-cell lymphoma | COST-EFFECTIVENESS | SINGLE-ADMINISTRATION PEGFILGRASTIM | RECEIVING CHEMOTHERAPY | PRIMARY PROPHYLAXIS | OPEN-LABEL | diffuse large B-cell lymphoma | CHOP CHEMOTHERAPY | 3-WEEKLY CHOP | FEBRILE NEUTROPENIA | pegylated G-CSF | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | DENSE RITUXIMAB | Doxorubicin - therapeutic use | Age Factors | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Filgrastim | Female | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Comorbidity | Risk Factors | Treatment Outcome | Recombinant Proteins - administration & dosage | Lymphoma, Large B-Cell, Diffuse - diagnosis | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Neoplasm Staging | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Granulocyte Colony-Stimulating Factor - administration & dosage | Care and treatment | Cyclophosphamide | Anthracyclines | Corticosteroids | Granulocyte colony-stimulating factor | Aluminum compounds | Aged patients | Lymphomas | Prednisone
Journal Article
by Li, XY and Huang, H and Xu, B and Guo, HQ and Lin, YC and Ye, S and Yi, JQ and Li, WY and Wu, XY and Wang, W and Zhang, HY and Xie, DR and Peng, JW and Cao, YB and Pu, XX and Guo, CC and Hong, HM and Wang, Z and Fang, XJ and Zhou, Y and Lin, SX and Liu, Q and Lin, TY
CANCER RESEARCH AND TREATMENT, ISSN 1598-2998, 07/2019, Volume 51, Issue 3, pp. 919 - 932
Journal Article
Journal of Comparative Effectiveness Research, ISSN 2042-6305, 11/2013, Volume 2, Issue 6, pp. 537 - 540
Evaluation of: Cunningham D, Hawkes EA, Jack A et al. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly... 
Phase III | DLBCL | R-CHOP-14 | R-CHOP | R-CHOP-21 | review | lymphoma | dose intensity | chemotherapy | DSHNHL | RANDOMIZED PHASE-3 TRIAL | RITUXIMAB | CYCLES | HEALTH CARE SCIENCES & SERVICES | NON-HODGKINS-LYMPHOMA | ELDERLY-PATIENTS | Female | Male | Lymphoma, Large B-Cell, Diffuse - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 2010, Volume 10, Issue 6, pp. 440 - 444
Journal Article
Journal Article
Clinical and Translational Oncology, ISSN 1699-048X, 09/2009, Volume 11, Issue 9, pp. 604 - 608
Journal Article
European Journal of Cancer Supplements, ISSN 1359-6349, 2008, Volume 6, Issue 2, pp. 31 - 36
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.